CompletedNCT00278772
Extended-release divalproex or placebo for hypomania or mild mania
About this title
Read the official source — NCT00278772Medication studyAges 18+United StatesBipolarity
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateAugust 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 62
- Sponsor
- Lindner Center of HOPE
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00278772
- Official title
Show the full official title
"A Randomized, Double-Blind, Placebo-Controlled Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to- Severe Hypomania or Mild Mania"
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Lindner Center of HOPE.
Did this study involve medication?
Yes. The study involved medication, including Divalproex.
Who was this study for?
Listed age limits: from 18 years.
